DrugPatentWatch Database Preview
Halozyme Therap Company Profile
» See Plans and Pricing
US Patents for Halozyme Therap
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Halozyme Therap | HYLENEX RECOMBINANT | hyaluronidase recombinant human | INJECTABLE;INJECTION | 021859 | 001 | 2005-12-02 | 8,431,380 | Halozyme, Inc. (San Diego, CA) | 2023-03-05 | RX | company | |
Halozyme Therap | HYLENEX RECOMBINANT | hyaluronidase recombinant human | INJECTABLE;INJECTION | 021859 | 001 | 2005-12-02 | 8,431,124 | Halozyme, Inc. (San Diego, CA) | 2023-03-05 | RX | company | |
Halozyme Therap | HYLENEX RECOMBINANT | hyaluronidase recombinant human | INJECTABLE;INJECTION | 021859 | 001 | 2005-12-02 | 8,202,517 | Halozyme, Inc. (San Diego, CA) | 2023-03-05 | RX | company | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |